Choice of immunotherapy vs targeted therapy in first line (BRAF)

Date 27 September 2014
Event ESMO 2014
Session Immunotherapy or targeted therapy for oncogene addicted melanoma
Topics Anti-Cancer Agents & Biologic Therapy
Cancer Immunology and Immunotherapy
Melanoma and other Skin Tumours
Presenter James Larkin
Authors J. Larkin
  • Department Of Medicine, Royal Marsden Hospital, SW3 6JJ - London/GB